6 December 2013
But chances of surviving lung cancer still lag behind breast, prostate and colorectal, warns charity
The proportion of breast, prostate and colorectal cancer patients dying from their illness in the UK will decrease by 44% between 1992 and 2020, whilst deaths from lung cancer will decrease by only 16%, according to new projections by Macmillan Cancer Support1.
The data compare the percentage of Britons diagnosed with one of the four most common cancers in the UK who die in a given year, and the proportion of them for whom the cancer is the cause of death.
In seven years time only one in three (36%) breast and prostate cancer patients and nearly two in five (39%) people with colorectal cancer will die from their cancer. Whereas a shocking three in four (76%) lung cancer patients will not survive their illness.
Previous Macmillan research estimated that by 2020 almost one in two people (47%) will get cancer in their lifetime but almost four in ten (38%) will not die from the disease2. However these new figures show that the trend is not consistent across even the most common cancers.
Professor Jane Maher, Chief Medical Officer at Macmillan Cancer Support, says:
'People diagnosed with three of the four most common cancers are more likely to survive but GPs need more support to help them diagnose lung cancer earlier. We’ve been working with the GP community to develop the tools that can help.'
Ciarán Devane, Chief Executive at Macmillan Cancer Support, says:
'Lung cancer patients deserve better. It is high time we closed the gap between survival rates for different cancers and give everyone the best possible chance of recovery.
'There are three key things that could help to achieve this. Firstly, we support the call for plain packaging of cigarettes to stop people taking up smoking, secondly we must catch the illness earlier through better awareness and we have to make sure access to surgery is more uniform across the country to reduce inequalities in cancer survival. It cannot be right that you are much more likely to get the surgery you need if you live in Leicestershire, than if you live in Lancashire.'
Macmillan is calling on the NHS to increase early diagnosis of lung cancer and to provide all patients with equal access to specialist surgery.
For detail of the analysis and methods supporting these new figures please see here.
No-one should face cancer alone. If you need information or support, please call 0808 808 00 00 or visit www.macmillan.org.uk.
For further information, please contact:
Claire Keuls, Senior Media & PR Officer, Macmillan Cancer Support
0207 840 4872 (out of hours 07801 307068)
Notes to Editors:
1 Macmillan Cancer Support indicative estimates based on available prevalence, incidence and mortality data. For more details of the analysis and methods see - Cancer mortality trends for top four cancers: 1992–2020.
2 Macmillan Cancer Support. Cancer mortality trends: 1992–2020 (May 2013)
http://www.macmillan.org.uk/Documents/AboutUs/Newsroom/Mortality-trends-2013-executive-summary-FINAL.pdf (accessed November 2013)
About Macmillan Cancer Support
More than one in three of us will get cancer. For most of us it will be the toughest fight we ever face. And the feelings of isolation and loneliness that so many people experience make it even harder.
But you don’t have to go through it alone. The Macmillan team is with you every step of the way.
We are the nurses and therapists helping you through treatment. The experts on the end of the phone. The advisers telling you which benefits you’re entitled to. The volunteers giving you a hand with the everyday things. The campaigners improving cancer care. The community there for you online, any time. The supporters who make it all possible.
Together, we are all Macmillan Cancer Support.